{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:02:32Z","timestamp":1790892152267,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11060-023-04265-y","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T14:02:48Z","timestamp":1678716168000},"page":"119-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS)"],"prefix":"10.1007","volume":"162","author":[{"given":"Michael","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten","family":"Myrehaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lin","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Detsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunit","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collins","family":"Yeboah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Lipsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leodante Da","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Holden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinthaka","family":"Heyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Maralani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ruschin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"4265_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2022.02.003","author":"V Gondi","year":"2022","unstructured":"Gondi V, Bauman G, Bradfield L, Burri SH, Cabrera AR, Cunningham DA et al (2022) Radiation therapy for brain metastases: an ASTRO clinical practice guideline. Pract Radiat Oncol. https:\/\/doi.org\/10.1016\/j.prro.2022.02.003","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"4265_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","volume":"17","author":"JH Suh","year":"2020","unstructured":"Suh JH, Kotecha R, Chao ST, Ahluwalia MS, Sahgal A, Chang EL (2020) Current approaches to the management of brain metastases. Nat Rev Clin Oncol 17(5):279\u2013299. https:\/\/doi.org\/10.1038\/s41571-019-0320-3","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"4265_CR3","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ijrobp.2014.10.024","volume":"91","author":"A Sahgal","year":"2015","unstructured":"Sahgal A, Aoyama H, Kocher M, Neupane B, Collette S, Tago M et al (2015) Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 91(4):710\u2013717. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.10.024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"4265_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/jco.21.02314","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D et al (2022) Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 40(5):492\u2013516. https:\/\/doi.org\/10.1200\/jco.21.02314","journal-title":"J Clin Oncol"},{"issue":"suppl2","key":"4265_CR5","doi-asserted-by":"publisher","first-page":"ii2","DOI":"10.1093\/neuonc\/nox001","volume":"19","author":"A Sahgal","year":"2017","unstructured":"Sahgal A, Ruschin M, Ma L, Verbakel W, Larson D, Brown PD (2017) Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues. Neurooncology 19(suppl2):ii2\u2013ii15. https:\/\/doi.org\/10.1093\/neuonc\/nox001","journal-title":"Neurooncology"},{"issue":"6","key":"4265_CR6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3171\/jns.2006.104.6.907","volume":"104","author":"MA Vogelbaum","year":"2006","unstructured":"Vogelbaum MA, Angelov L, Lee S-Y, Li L, Barnett GH, Suh JH (2006) Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 104(6):907\u2013912. https:\/\/doi.org\/10.3171\/jns.2006.104.6.907","journal-title":"J Neurosurg"},{"issue":"2","key":"4265_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3171\/2014.10.jns141610","volume":"123","author":"PK Sneed","year":"2015","unstructured":"Sneed PK, Mendez J, Vemer-Van Den Hoek JGM, Seymour ZA, Ma L, Molinaro AM et al (2015) Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg 123(2):373\u2013386. https:\/\/doi.org\/10.3171\/2014.10.jns141610","journal-title":"J Neurosurg"},{"issue":"1","key":"4265_CR8","first-page":"1","volume":"8","author":"R Singh","year":"2022","unstructured":"Singh R, Didwania P, Lehrer EJ, Palmer JD, Trifiletti DM, Sheehan JP (2022) Repeat stereotactic radiosurgery for locally recurrent brain metastases previously treated with stereotactic radiosurgery: a systematic review and meta-analysis of efficacy and safety. J Radiosurg SBRT 8(1):1\u201310","journal-title":"J Radiosurg SBRT"},{"key":"4265_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09317-6","author":"N He\u00dfler","year":"2022","unstructured":"He\u00dfler N, J\u00fcnger ST, Meissner A-K, Kocher M, Goldbrunner R, Grau S (2022) Recurrent brain metastases: the role of resection of in a comprehensive multidisciplinary treatment setting. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-022-09317-6","journal-title":"BMC Cancer"},{"issue":"8","key":"4265_CR10","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1200\/jco.2005.04.6235","volume":"24","author":"MA Vogelbaum","year":"2006","unstructured":"Vogelbaum MA, Suh JH (2006) Resectable brain metastases. J Clin Oncol 24(8):1289\u20131294. https:\/\/doi.org\/10.1200\/jco.2005.04.6235","journal-title":"J Clin Oncol"},{"issue":"1","key":"4265_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/neuonc\/noz144","volume":"22","author":"TK Nguyen","year":"2020","unstructured":"Nguyen TK, Sahgal A, Detsky J, Atenafu EG, Myrehaug S, Tseng C-L et al (2020) Predictors of leptomeningeal disease following hypofractionated stereotactic radiotherapy for intact and resected brain metastases. Neurooncology 22(1):84\u201393. https:\/\/doi.org\/10.1093\/neuonc\/noz144","journal-title":"Neurooncology"},{"issue":"5","key":"4265_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jamaoncol.2018.7204","volume":"5","author":"DN Cagney","year":"2019","unstructured":"Cagney DN, Lamba N, Sinha S, Catalano PJ, Bi WL, Alexander BM et al (2019) Association of neurosurgical resection with development of pachymeningeal seeding in patients with brain metastases. JAMA Oncol 5(5):703. https:\/\/doi.org\/10.1001\/jamaoncol.2018.7204","journal-title":"JAMA Oncol"},{"issue":"2","key":"4265_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ijrobp.2017.09.047","volume":"100","author":"H Soliman","year":"2018","unstructured":"Soliman H, Ruschin M, Angelov L, Brown PD, Chiang VLS, Kirkpatrick JP et al (2018) Consensus contouring guidelines for postoperative completely resected cavity stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 100(2):436\u2013442. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.09.047","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4265_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.nec.2020.06.004","volume":"31","author":"E Luther","year":"2020","unstructured":"Luther E, Mansour S, Echeverry N, McCarthy D, Eichberg DG, Shah A et al (2020) Laser ablation for cerebral metastases. Neurosurg Clin N Am 31(4):537\u2013547. https:\/\/doi.org\/10.1016\/j.nec.2020.06.004","journal-title":"Neurosurg Clin N Am"},{"issue":"Supplement5","key":"4265_CR15","doi-asserted-by":"publisher","first-page":"v16","DOI":"10.1093\/noajnl\/vdab128","volume":"3","author":"ES Srinivasan","year":"2021","unstructured":"Srinivasan ES, Grabowski MM, Nahed BV, Barnett GH, Fecci PE (2021) Laser interstitial thermal therapy for brain metastases. Neuro-Oncol Adv 3(Supplement5):v16\u2013v25. https:\/\/doi.org\/10.1093\/noajnl\/vdab128","journal-title":"Neuro-Oncol Adv"},{"key":"4265_CR16","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1016\/j.wneu.2020.03.213","volume":"139","author":"J Shao","year":"2020","unstructured":"Shao J, Radakovich NR, Grabowski M, Borghei-Razavi H, Knusel K, Joshi KC et al (2020) Lessons learned in using laser interstitial thermal therapy for treatment of brain tumors: a case series of 238 patients from a single Institution. World Neurosurg 139:e345\u2013e54. https:\/\/doi.org\/10.1016\/j.wneu.2020.03.213","journal-title":"World Neurosurg"},{"issue":"9","key":"4265_CR17","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/s41591-022-01935-8","volume":"28","author":"R Bartsch","year":"2022","unstructured":"Bartsch R, Berghoff AS, Furtner J, Marhold M, Bergen ES, Roider-Schur S et al (2022) Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial. Nat Med 28(9):1840\u20131847. https:\/\/doi.org\/10.1038\/s41591-022-01935-8","journal-title":"Nat Med"},{"key":"4265_CR18","doi-asserted-by":"publisher","DOI":"10.1200\/edbk_352320","author":"C Alvarez-Breckenridge","year":"2022","unstructured":"Alvarez-Breckenridge C, Remon J, Pi\u00f1a Y, Nieblas-Bedolla E, Forsyth P, Hendriks L et al (2022) Emerging systemic treatment perspectives on brain metastases: moving toward a better outlook for patients. Am Soc Clin Oncol Educational Book. https:\/\/doi.org\/10.1200\/edbk_352320","journal-title":"Am Soc Clin Oncol Educational Book"},{"key":"4265_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fonc.2018.00161","volume":"8","author":"F Franchino","year":"2018","unstructured":"Franchino F, Ruda R, Soffietti R (2018) Mechanisms and therapy for Cancer metastasis to the brain. Front Oncol 8:161. https:\/\/doi.org\/10.3389\/fonc.2018.00161","journal-title":"Front Oncol"},{"issue":"3","key":"4265_CR20","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.ijrobp.2021.10.008","volume":"112","author":"RO Kowalchuk","year":"2022","unstructured":"Kowalchuk RO, Niranjan A, Lee CC, Yang HC, Liscak R, Guseynova K et al (2022) Reirradiation with stereotactic radiosurgery after local or marginal recurrence of brain metastases from previous radiosurgery. Int J Radiat Oncol Biol Phys 112(3):726\u2013734. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.10.008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4265_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11060-015-1937-4","volume":"126","author":"G Minniti","year":"2016","unstructured":"Minniti G, Scaringi C, Paolini S, Clarke E, Cicone F, Esposito V et al (2016) Repeated stereotactic radiosurgery for patients with progressive brain metastases. J Neurooncol 126(1):91\u201397. https:\/\/doi.org\/10.1007\/s11060-015-1937-4","journal-title":"J Neurooncol"},{"issue":"1","key":"4265_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3171\/2016.5.jns153051","volume":"127","author":"WH Mckay","year":"2017","unstructured":"Mckay WH, Mctyre ER, Okoukoni C, Alphonse-Sullivan NK, Ruiz J, Munley MT et al (2017) Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. J Neurosurg 127(1):148\u2013156. https:\/\/doi.org\/10.3171\/2016.5.jns153051","journal-title":"J Neurosurg"},{"key":"4265_CR23","doi-asserted-by":"publisher","DOI":"10.3171\/2022.4.jns212597","author":"PK Sneed","year":"2022","unstructured":"Sneed PK, Chan JW, Ma L, Braunstein SE, Theodosopoulos PV, Fogh SE et al (2022) Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases. J Neurosurg. https:\/\/doi.org\/10.3171\/2022.4.jns212597","journal-title":"J Neurosurg"},{"issue":"3","key":"4265_CR24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11060-022-04115-3","volume":"159","author":"M Yan","year":"2022","unstructured":"Yan M, Holden L, Wang M, Soliman H, Myrehaug S, Tseng C-L et al (2022) Gamma knife icon based hypofractionated stereotactic radiosurgery (GKI-HSRS) for brain metastases: impact of dose and volume. J Neurooncol 159(3):705\u2013712. https:\/\/doi.org\/10.1007\/s11060-022-04115-3","journal-title":"J Neurooncol"},{"issue":"1","key":"4265_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/cancers13010070","volume":"13","author":"T Gutschenritter","year":"2020","unstructured":"Gutschenritter T, Venur VA, Combs SE, Vellayappan B, Patel AP, Foote M et al (2020) The judicious use of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy in the management of large brain metastases. Cancers 13(1):70. https:\/\/doi.org\/10.3390\/cancers13010070","journal-title":"Cancers"},{"issue":"3","key":"4265_CR26","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ijrobp.2018.10.038","volume":"103","author":"EJ Lehrer","year":"2019","unstructured":"Lehrer EJ, Peterson JL, Zaorsky NG, Brown PD, Sahgal A, Chiang VL et al (2019) Single versus multifraction stereotactic radiosurgery for large brain metastases: an international meta-analysis of 24 trials. Int J Radiat Oncol Biol Phys 103(3):618\u2013630. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.10.038","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"14","key":"4265_CR27","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1158\/1078-0432.ccr-16-2265","volume":"23","author":"H Mehrabian","year":"2017","unstructured":"Mehrabian H, Desmond KL, Soliman H, Sahgal A, Stanisz GJ (2017) Differentiation between radiation necrosis and tumor progression using chemical exchange saturation transfer. Clin Cancer Res 23(14):3667\u20133675. https:\/\/doi.org\/10.1158\/1078-0432.ccr-16-2265","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4265_CR28","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/neuonc\/noaa007","volume":"22","author":"A Mouraviev","year":"2020","unstructured":"Mouraviev A, Detsky J, Sahgal A, Ruschin M, Lee YK, Karam I et al (2020) Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery. Neurooncology 22(6):797\u2013805. https:\/\/doi.org\/10.1093\/neuonc\/noaa007","journal-title":"Neurooncology"},{"issue":"5","key":"4265_CR29","doi-asserted-by":"publisher","first-page":"E860","DOI":"10.1093\/neuros\/nyz162","volume":"85","author":"H Soliman","year":"2019","unstructured":"Soliman H, Myrehaug S, Tseng C-L, Ruschin M, Hashmi A, Mainprize T et al (2019) Image-guided, linac-based, surgical cavity-hypofractionated stereotactic radiotherapy in 5 daily fractions for brain metastases. Neurosurgery 85(5):E860\u2013E869. https:\/\/doi.org\/10.1093\/neuros\/nyz162","journal-title":"Neurosurgery"},{"key":"4265_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.09.003","author":"S Myrehaug","year":"2021","unstructured":"Myrehaug S, Hudson J, Soliman H, Ruschin M, Tseng CL, Detsky J et al (2021) Hypofractionated stereotactic radiation therapy for intact brain metastases in 5 daily fractions: effect of dose on treatment response. Int J Radiat Oncol Biol Phys. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.09.003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"4265_CR31","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/s1470-2045(15)70057-4","volume":"16","author":"NU Lin","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16(6):e270\u2013e278. https:\/\/doi.org\/10.1016\/s1470-2045(15)70057-4","journal-title":"Lancet Oncol"},{"issue":"4","key":"4265_CR32","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ijrobp.2019.12.002","volume":"106","author":"S Faruqi","year":"2020","unstructured":"Faruqi S, Ruschin M, Soliman H, Myrehaug S, Zeng KL, Husain Z et al (2020) Adverse radiation effect after hypofractionated stereotactic radiosurgery in 5 daily fractions for surgical cavities and intact brain metastases. Int J Radiat Oncol Biol Phys 106(4):772\u2013779. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.12.002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"4265_CR33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3340\/jkns.2017.0238","volume":"61","author":"I-Y Kim","year":"2018","unstructured":"Kim I-Y, Jung S, Jung T-Y, Moon K-S, Jang W-Y, Park J-Y et al (2018) Repeat stereotactic radiosurgery for recurred metastatic brain tumors. J Korean Neurosurg Soc 61(5):633\u2013639. https:\/\/doi.org\/10.3340\/jkns.2017.0238","journal-title":"J Korean Neurosurg Soc"},{"key":"4265_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.wneu.2017.04.103","volume":"104","author":"P Koffer","year":"2017","unstructured":"Koffer P, Chan J, Rava P, Gorovets D, Ebner D, Savir G et al (2017) Repeat stereotactic radiosurgery for locally recurrent brain metastases. World Neurosurg 104:589\u2013593. https:\/\/doi.org\/10.1016\/j.wneu.2017.04.103","journal-title":"World Neurosurg"},{"key":"4265_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.radonc.2020.12.011","volume":"156","author":"N Andruska","year":"2021","unstructured":"Andruska N, Kennedy WR, Bonestroo L, Anderson R, Huang Y, Robinson CG et al (2021) Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastases. Radiother Oncol 156:181\u2013187. https:\/\/doi.org\/10.1016\/j.radonc.2020.12.011","journal-title":"Radiother Oncol"},{"key":"4265_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fonc.2017.00279","volume":"7","author":"N Rana","year":"2017","unstructured":"Rana N, Pendyala P, Cleary RK, Luo G, Zhao Z, Chambless LB et al (2017) Long-term outcomes after salvage stereotactic radiosurgery (SRS) following in-field failure of initial SRS for brain metastases. Front Oncol 7:279. https:\/\/doi.org\/10.3389\/fonc.2017.00279","journal-title":"Front Oncol"},{"issue":"2","key":"4265_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3171\/2017.3.jns162532","volume":"129","author":"L Angelov","year":"2018","unstructured":"Angelov L, Mohammadi AM, Bennett EE, Abbassy M, Elson P, Chao ST et al (2018) Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases \u2265 2\u00a0cm. J Neurosurg 129(2):366\u2013382. https:\/\/doi.org\/10.3171\/2017.3.jns162532","journal-title":"J Neurosurg"},{"issue":"5","key":"4265_CR38","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.ijrobp.2008.10.035","volume":"74","author":"Y Higuchi","year":"2009","unstructured":"Higuchi Y, Serizawa T, Nagano O, Matsuda S, Ono J, Sato M et al (2009) Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors. Int J Radiat Oncol Biol Phys 74(5):1543\u20131548. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.10.035","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4265_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11060-017-2545-2","volume":"134","author":"JS Detsky","year":"2017","unstructured":"Detsky JS, Keith J, Conklin J, Symons S, Myrehaug S, Sahgal A et al (2017) Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology. J Neurooncol 134(2):433\u2013441. https:\/\/doi.org\/10.1007\/s11060-017-2545-2","journal-title":"J Neurooncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04265-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04265-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04265-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T04:12:55Z","timestamp":1679976775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04265-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["4265"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04265-y","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"20 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HS reports travel and education grants from Elekta. SD reports research grants from Alkermes Medical and consultant fees from Medexus. SM reports research support and honoraria from AAA\/Novartis and Ipsen. CLT reports honoraria from Elekta and serves on the advisory board for Sanofi. AS reports consulting fees and grants from Varian and Elekta, as well as honoraria from Varian, BrainLab, and Elekta. MR owns intellectual property related to the image-guidance component on the Elekta Gamma Knife system. All other authors have no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}